Esomeprazole ๐
๐ About
- Always check the BNF entry for the most up-to-date prescribing advice.
- Esomeprazole is the S-isomer of omeprazole, a proton pump inhibitor (PPI) used to suppress gastric acid secretion.
โ๏ธ Mode of Action
- Irreversibly inhibits the Hโบ/Kโบ-ATPase proton pump in gastric parietal cells.
- Blocks the final step in acid secretion โ sustained reduction in gastric acidity.
- Promotes ulcer healing and reduces oesophageal mucosal damage from reflux.
๐ Indications & Example Doses
- GORD / reflux oesophagitis: 20โ40 mg PO daily (maintenance 20 mg daily).
- Peptic ulcer disease (PUD): 20 mg PO daily for 4โ8 weeks.
- H. pylori eradication (with 2 antibiotics): 20 mg PO BD for 7 days.
- NSAID-associated ulcer prophylaxis: 20 mg PO daily.
- ZollingerโEllison syndrome: 40 mg PO BD (titrate to control symptoms).
โ ๏ธ Doses may vary depending on indication and patient factors - always check BNF/local guidelines.
๐ Interactions
- PPI use may reduce the effectiveness of clopidogrel (CYP2C19 inhibition).
- Can โ levels of drugs dependent on gastric pH for absorption (e.g. ketoconazole, atazanavir).
โ ๏ธ Cautions
- Long-term use: risk of vitamin B12 deficiency, hypomagnesaemia, osteoporosis/fractures.
- Increased risk of Clostridioides difficile diarrhoea and other enteric infections.
- Masking of gastric cancer symptoms - review need if persistent dyspepsia.
๐ซ Contraindications
- Hypersensitivity to esomeprazole, omeprazole, or other substituted benzimidazoles.
๐ฅ Side Effects
- Common: GI upset (diarrhoea, constipation, abdominal pain), headache.
- Occasional: nausea, flatulence, dry mouth, dizziness.
- Rare but important: C. difficile infection, interstitial nephritis, subacute cutaneous lupus, hyponatraemia.
๐ References